Global Assets Advisory LLC Takes $1.33 Million Position in Henry Schein, Inc. (NASDAQ:HSIC)

Global Assets Advisory LLC acquired a new position in shares of Henry Schein, Inc. (NASDAQ:HSIC) during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 17,669 shares of the company’s stock, valued at approximately $1,334,000.

A number of other hedge funds have also recently added to or reduced their stakes in HSIC. McGlone Suttner Wealth Management Inc. bought a new stake in shares of Henry Schein during the 4th quarter valued at about $39,000. Neo Ivy Capital Management acquired a new position in Henry Schein in the third quarter valued at approximately $46,000. Mather Group LLC. bought a new position in shares of Henry Schein during the first quarter valued at approximately $97,000. Benjamin F. Edwards & Company Inc. raised its position in shares of Henry Schein by 37.8% during the 4th quarter. Benjamin F. Edwards & Company Inc. now owns 1,516 shares of the company’s stock worth $114,000 after purchasing an additional 416 shares during the period. Finally, GAMMA Investing LLC bought a new stake in shares of Henry Schein in the 4th quarter worth approximately $115,000. Institutional investors and hedge funds own 96.62% of the company’s stock.

Henry Schein Stock Performance

Shares of HSIC opened at $64.56 on Thursday. Henry Schein, Inc. has a one year low of $60.01 and a one year high of $82.63. The company has a debt-to-equity ratio of 0.47, a current ratio of 1.75 and a quick ratio of 1.02. The stock has a market cap of $8.27 billion, a price-to-earnings ratio of 21.81, a PEG ratio of 1.63 and a beta of 0.90. The company has a 50-day moving average of $70.16 and a two-hundred day moving average of $73.00.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Tuesday, May 7th. The company reported $1.10 earnings per share for the quarter, beating the consensus estimate of $1.01 by $0.09. The firm had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.21 billion. Henry Schein had a return on equity of 13.51% and a net margin of 3.12%. Henry Schein’s quarterly revenue was up 3.7% on a year-over-year basis. During the same period in the previous year, the firm earned $1.21 earnings per share. On average, equities research analysts expect that Henry Schein, Inc. will post 5.16 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on HSIC shares. UBS Group dropped their target price on Henry Schein from $82.00 to $80.00 and set a “neutral” rating on the stock in a research report on Wednesday, May 8th. Piper Sandler reissued an “overweight” rating and set a $86.00 target price on shares of Henry Schein in a research note on Friday, June 21st. Barrington Research upped their target price on shares of Henry Schein from $90.00 to $92.00 and gave the stock an “outperform” rating in a research report on Wednesday, May 8th. JPMorgan Chase & Co. lifted their price target on Henry Schein from $82.00 to $88.00 and gave the company an “overweight” rating in a report on Wednesday, March 6th. Finally, Evercore ISI increased their price objective on Henry Schein from $79.00 to $83.00 and gave the stock an “in-line” rating in a report on Wednesday, February 28th. One research analyst has rated the stock with a sell rating, six have given a hold rating and five have issued a buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $81.73.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.